Ligosan

Doxycycline, the active ingredient in Ligosan, is a tetracycline antibiotic presented as a topical formulation for periodontal (local) use. It is employed to treat periodontal disease and chronic periodontitis by targeting the bacterial infection within the gum tissues.

GNH USA supplies Ligosan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches for global distribution, with a supply chain that supports timely delivery and import‑compliance documentation.

Ligosan (doxycycline) is indicated for bacterial infections of the periodontal tissues and related chronic conditions.

- Periodontal disease: reduces bacterial load and inflammation in the gums, supporting healing after mechanical debridement. - Chronic periodontitis: helps control infection and limits further attachment loss when used as an adjunct to scaling and root planing. - Aggressive periodontitis: provides targeted antimicrobial activity to complement conventional periodontal therapy.

Adverse reactions to Ligosan are generally related to its systemic absorption and local application.

Common Side Effects: - Nausea or upset stomach. - Diarrhea or loose stools. - Photosensitivity leading to easy sunburn. - Altered taste sensation. - Mild oral irritation at the application site. - Transient headache.

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic toxicity presenting as jaundice or elevated liver enzymes. - Intracranial hypertension with headache and visual changes. - Severe photosensitivity causing blistering. - Clostridioides difficile‑associated colitis.

Before prescribing Ligosan, clinicians should consider several safety factors.

- Pregnancy: Category D – use only if potential benefit justifies the risk to the fetus. - Breastfeeding: Doxycycline is excreted in milk; caution advised. - Renal impairment: dose adjustment may be required; monitor renal function. - Children under 8 years: avoid due to risk of permanent tooth discoloration. - Concurrent anticoagulant therapy: may enhance anticoagulant effect; monitor coagulation parameters. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Doxycycline can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids, calcium, magnesium or iron supplements – they chelate doxycycline and markedly reduce absorption. - Warfarin – doxycycline may potentiate anticoagulant effect, increasing bleeding risk. - Retinoids – combined use can raise the risk of intracranial hypertension.

Moderate Interactions (Monitor Closely): - Oral contraceptives – doxycycline may diminish contraceptive effectiveness; advise backup method. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) – concurrent use can increase risk of renal toxicity. - Macrolide antibiotics – additive antibacterial activity may increase the chance of gut flora disturbance.